We use FDA-approved treatmentsincluding GLP-1s like Ozempic, Lipo B12 and Lipo-Mino injections, appetite suppressants, and IV infusion therapyto help you curb cravings, boost your metabolism, and see real, lasting results
MASH is directly tied to obesity, insulin resistance, and the same metabolic milieu that drives cardiovascular disease
Many women maintain good health after discontinuing GLP-1 therapy and throughout pregnancy
thats considered off-label use, which, if you want to draw from an HSA or FSA, requires a Letter of Medical Necessity (LMN)
As discussed previously, even postprandial GLP1 levels boosted by the administration of DPP4 inhibitors do not elicit reductions in food intake or nausea